(a) At the time of dispensing nPEP, a pharmacist registered with the Program shall: (1) Screen the patient to determine that HIV exposure occurred within 72 hours before the dispensing; (2) Determine whether the patient meets clinical criteria consistent with the most recent CDC Guidelines, including: (i) The identification of any contraindicated medications; and (ii) If applicable, exposure as the result of an alleged rape or sexual offense or alleged child sexual abuse; (3) Subject to subsection (b) of this section, determine whether an available standing order is appropriate for the patient and dispense nPEP in accordance with the most recent CDC Guidelines; (4) Refer the patient to a disease intervention specialist within the Department for ongoing treatment; and (5) Determine whether the patient has a primary care provider and: (i) If the patient has a primary care provider, notify the provider that the patient was dispensed nPEP; or (ii) If the patient does not have a primary care provider, provide the patient with a list of local primary care providers and clinics provided by the Department. (b) If an available standing order is not appropriate for the patient, the pharmacist shall refer the patient to a primary care provider. (c) A pharmacist may dispense nPEP in accordance with a therapy management contract under Title 12, Subtitle 6A of the Health Occupations Article.
‹ Prev All Maryland sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.